In the previous study, they interviewed 16 transgender patients about their experiences with breast/chest cancer risk assessment and top surgery. In the current study, they interviewed 20 healthcare professionals – primary care physicians, genetic counselors, oncologists and plastic surgeons – about current practices and barriers to breast/chest cancer risk assessments for these patients. “Many healthcare professionals caring for transgender patients want to help, but there is currently no standardized conversation about breast/chest cancer risk (e.g. what screening looks like after surgery or whether they should consider having more tissue removed based on a genetic or familial risk for cancer),” adds Zayhowski. To help patients deal with specific barriers to breast/chest cancer risk assessment in transgender care that have been identified, the team of researchers is in the process of developing CHESTcare – Cancer & Hereditary Risk Education & Support for Transgender and nonbinary individuals – an online toolkit that integrates cancer and hereditary risk education with support for informed decision-making about breast/chest cancer screening in the context of gender-affirming care.